Fundraising Fox
Greg Brown
InvestorAdvisory Board - Healthcare Royalty Investing Pioneer at FemHealth Ventures · Advisor at Bering Capital
Houston, Texas, United States
Find your path to Greg
Sign up to see every warm intro you have to Greg
- Paths you didn't know you had: your email and LinkedIn already hold routes to Greg. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
About
Gregory B. Brown, M.D. is CEO and a director of Memgen, Inc., a development-stage company working on next-generation viral immunotherapeutics including oncolytic viruses. He co-founded HCR Partners, a healthcare-focused asset management firm, and was previously a partner at Paul Capital Partners where he co-managed royalty investments; earlier he was co-head of investment banking and head of healthcare at Adams, Harkness & Hill and a biotechnology research analyst at Vector Securities International. Trained as a transplantation immunologist and thoracic and vascular surgeon, he holds a B.A. from Yale College, an M.D. from SUNY Upstate Medical Center, and an M.B.A. from Harvard Business School.
Invests in
BiotechHealthtechMedical Devices
Investments
Board seats
Aquestive Therapeutics, Inc.Caladrius Biosciences, Inc.Faron Pharmaceuticals OyFAST BioMedicalMemgen, Inc
Per the firm's website.
Colleagues at FemHealth Ventures
Frequently asked questions
- Who is Greg Brown?
- Gregory B. Brown, M.D. is CEO and a director of Memgen, Inc., a development-stage company working on next-generation viral immunotherapeutics including oncolytic viruses. He co-founded HCR Partners, a healthcare-focused asset management firm, and was previously a partner at Paul Capital Partners where he co-managed royalty investments; earlier he was co-head of investment banking and head of healthcare at Adams, Harkness & Hill and a biotechnology research analyst at Vector Securities International. Trained as a transplantation immunologist and thoracic and vascular surgeon, he holds a B.A. from Yale College, an M.D. from SUNY Upstate Medical Center, and an M.B.A. from Harvard Business School.
- Where does Greg Brown work?
- Greg Brown is Advisory Board - Healthcare Royalty Investing Pioneer at FemHealth Ventures and Advisor at Bering Capital.
- What does Greg Brown invest in?
- Greg Brown invests in Biotech, Healthtech, Medical Devices.
- What boards does Greg Brown sit on?
- Greg Brown holds tracked board seats at Aquestive Therapeutics, Inc., Caladrius Biosciences, Inc., Faron Pharmaceuticals Oy, FAST BioMedical, Memgen, Inc.
About this profile. Compiled from public sources — FemHealth Ventures's own website and public professional profiles — and summarised by Fundraising Fox; every fact is kept with where it came from. Spotted an error, or would rather not be listed? Email privacy@fundraisingfox.com · How we build profiles · Your rights